Pennsylvania HB 2182: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Bill Text

PRINTER'S NO. 2836
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No. 2182
Session of
2026
INTRODUCED BY PIELLI, MUNROE, McNEILL, HILL-EVANS, SANCHEZ,
BRENNAN, D. WILLIAMS, O'MARA, GREEN, HANBIDGE, DALEY, CEPEDA-
FREYTIZ AND BOROWSKI, JANUARY 30, 2026
REFERRED TO COMMITTEE ON HEALTH, JANUARY 30, 2026
AN ACT
Amending the act of April 14, 1972 (P.L.233, No.64), entitled
"An act relating to the manufacture, sale and possession of
controlled substances, other drugs, devices and cosmetics;
conferring powers on the courts and the secretary and
Department of Health, and a newly created Pennsylvania Drug,
Device and Cosmetic Board; establishing schedules of
controlled substances; providing penalties; requiring
registration of persons engaged in the drug trade and for the
revocation or suspension of certain licenses and
registrations; and repealing an act," further providing for
drug overdose medication.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 13.8(a)(1) of the act of April 14, 1972
(P.L.233, No.64), known as The Controlled Substance, Drug,
Device and Cosmetic Act, is amended to read:
Section 13.8. Drug Overdose Medication.--(a) The
department, in carrying out its duties under 28 Pa. Code Ch.
1023 (relating to personnel), shall have the following duties:
(1) Amend the prehospital practitioner scope of practice of
emergency medical services providers to include the
administration of an opioid antagonist, including naloxone and
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22

nalmefene.
* * *
Section 2. This act shall take effect in 60 days.
20260HB2182PN2836 - 2 -
1
2
3